Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Arthritis and Rheumatism|February 12, 2004
Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritisFloris A van Gaalen, Rene E M Toes, Henrik J Ditzel, et al.
Arthritis and Rheumatism|October 17, 2002
A randomized comparison of care provided by a clinical nurse specialist, an inpatient team, and a day patient team in rheumatoid arthritisGerhardus J Tijhuis, Aeilko H Zwinderman, Johanna M W Hazes, et al.
Lancet (London, England)|July 19, 2008
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trialPaul Emery, Ferdinand C Breedveld, Stephen Hall, et al.
Clinical Rheumatology|March 20, 2008
An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody statusArie E van der Bijl, Ferdinand C Breedveld, Christian E Antoni, et al.
Arthritis and Rheumatism|October 13, 2004
Comparison of manual therapy and exercise therapy in osteoarthritis of the hip: a randomized clinical trialHugo L Hoeksma, Joost Dekker, H Karel Ronday, et al.
Arthritis and Rheumatism|February 1, 2007
A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisionsAnnette H M van der Helm-van Mil, Saskia le Cessie, Henrike van Dongen, et al.
Arthritis and Rheumatism|December 31, 2005
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatmentFerdinand C Breedveld, Michael H Weisman, Arthur F Kavanaugh, et al.
Arthritis and Rheumatism|March 31, 2006
The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritisAnnette H M van der Helm-van Mil, Kirsten N Verpoort, Ferdinand C Breedveld, et al.
Arthritis and Rheumatism|June 30, 2005
Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritisTanja C A Tolboom, Annette H M van der Helm-Van Mil, Rob G H H Nelissen, et al.
Arthritis and Rheumatism|February 13, 2002
Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imagingRichard J Reece, Maarten C Kraan, Aleksandra Radjenovic, et al.
Pageof 9